Edward V Nunes (Edward Nunes)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 35

Top Venues

Addiction (Abingdon, England)

medRxiv : the preprint server for health sciences

The American journal on addictions

Neuropsychiatric disease and treatment

Columbia University Irving Medical Center/New York State Psychiatric Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Columbia University Irving Medical Center/New York State Psychiatric Institute Jul 01 1985

United States

Professor :: Psychiatry

Publications

Rachael K Ross, Edward V Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A Stuart, Kara E Rudolph
Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. medRxiv : the preprint server for health sciences (2024)
Rachael K Ross, Edward V Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A Stuart, Kara E Rudolph
Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. medRxiv : the preprint server for health sciences (2024)
Rachael K Ross, Edward V Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A Stuart, Kara E Rudolph
Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. medRxiv : the preprint server for health sciences (2024)
Rachael K Ross, Edward V Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A Stuart, Kara E Rudolph
Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. medRxiv : the preprint server for health sciences (2024)
Rachael K Ross, Edward V Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A Stuart, Kara E Rudolph
Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. medRxiv : the preprint server for health sciences (2024)
Rachael K Ross, Edward V Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A Stuart, Kara E Rudolph
Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. medRxiv : the preprint server for health sciences (2024)
Rachael K Ross, Edward V Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A Stuart, Kara E Rudolph
Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. medRxiv : the preprint server for health sciences (2024)
Rachael K Ross, Edward V Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A Stuart, Kara E Rudolph
Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. Addiction (Abingdon, England) (2024)
Rachael K Ross, Edward V Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A Stuart, Kara E Rudolph
Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. medRxiv : the preprint server for health sciences (2024)
Rachael K Ross, Edward V Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A Stuart, Kara E Rudolph
Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients. Addiction (Abingdon, England) (2024)
Corey J Hayes, Rebecca A Raciborski, Matthew Nowak, Mahip Acharya, Edward V Nunes, Theresa M Winhusen
Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type. Addiction (Abingdon, England) (2024)
Joseph M Trombello, Alexandra Kulikova, Taryn L Mayes, Karabi Nandy, Thomas Carmody, Gavin Bart, Edward V Nunes, Joy Schmitz, Mariah Kalmin, Steven Shoptaw, Madhukar H Trivedi
Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR 16 ) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial. Neuropsychiatric disease and treatment 19 (2023)
Margaret M Paschen-Wolff, Shelly F Greenfield, R Kathryn McHugh, Kathleen Burlew, Martina Pavlicova, Tse-Hwei Choo, Celestina Barbosa-Leiker, Lesia M Ruglass, Sarah Mennenga, John Rotrosen, Edward V Nunes, Aimee N C Campbell
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder. The American journal on addictions (2023)
Joseph M Trombello, Alexandra Kulikova, Taryn L Mayes, Karabi Nandy, Thomas Carmody, Gavin Bart, Edward V Nunes, Joy Schmitz, Mariah Kalmin, Steven Shoptaw, Madhukar H Trivedi
Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR 16 ) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial. Neuropsychiatric disease and treatment 19 (2023)
Joseph M Trombello, Alexandra Kulikova, Taryn L Mayes, Karabi Nandy, Thomas Carmody, Gavin Bart, Edward V Nunes, Joy Schmitz, Mariah Kalmin, Steven Shoptaw, Madhukar H Trivedi
Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR 16 ) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial. Neuropsychiatric disease and treatment 19 (2023)
Noel A Vest, Kevin Wenzel, Tse-Hwei Choo, Martina Pavlicova, John Rotrosen, Edward V Nunes, Joshua D Lee, Marc Fishman
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial. The American journal on addictions (2023)
Paul J Joudrey, Gavin Bart, Robert K Brooner, Lawrence Brown, Julie Dickson-Gomez, Adam J Gordon, Sarah S Kawasaki, Jane M Liebschutz, Edward V Nunes, Dennis McCarty, Robert P Schwartz, José Szapocnik, Madhukar Trivedi, Judith I Tsui, Arthur Williams, Li-Tzy Wu, David A Fiellin
Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report. Substance abuse 42 (3) (2022)
Sarah Kawasaki, Sara Mills-Huffnagle, Nicole Aydinoglo, Halley Maxin, Edward V Nunes
Patient- and Provider-Reported Experiences of a Mobile Novel Digital Therapeutic in People With Opioid Use Disorder (reSET-O): Feasibility and Acceptability Study. JMIR formative research 6 (3) (2022)
Abhinav Suri, Daniel J Feaster, Raymond R Balise, James Quinn, Edward V Nunes, Louisa Gilbert, Nabila El-Bassel, Andrew Graham Rundle
Impacts of the New York State COVID-19 Disaster Emergency Orders on prescription dispensing for opioids and medication for opioid use disorder. Addiction (Abingdon, England) (2022)
Miranda G Greiner, Matisyahu Shulman, Jennifer Scodes, Tse-Hwei Choo, Martina Pavlicova, Onumara Opara, Aimee N C Campbell, Patricia Novo, Marc Fishman, Joshua D Lee, John Rotrosen, Edward V Nunes
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone. Substance use & misuse 57 (11) (2022)
Yuri A Maricich, Edward V Nunes, Aimee N C Campbell, Jeffrey D Botbyl, Hilary F Luderer
Safety and efficacy of a digital therapeutic for substance use disorder: Secondary analysis of data from a NIDA clinical trials network study. Substance abuse 43 (1) (2022)
Kara E Rudolph, Iván Díaz, Nima S Hejazi, Mark J van der Laan, Sean X Luo, Matisyahu Shulman, Aimee Campbell, John Rotrosen, Edward V Nunes
Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables. Addiction (Abingdon, England) 116 (8) (2021)
Sean M Murphy, Philip J Jeng, Kathryn E McCollister, Jared A Leff, Ali Jalali, Matisyahu Shulman, Joshua D Lee, Edward V Nunes, Patricia Novo, John Rotrosen, Bruce R Schackman
Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis. Addiction (Abingdon, England) 116 (12) (2021)
Kara E Rudolph, Matisyahu Shulman, Marc Fishman, Iván Díaz, John Rotrosen, Edward V Nunes
Association between dynamic dose increases of buprenorphine for treatment of opioid use disorder and risk of relapse. Addiction (Abingdon, England) (2021)
Sarah E Lord, Aimee N C Campbell, Mary F Brunette, Leonardo Cubillos, Sophia M Bartles, William C Torrey, Ardis L Olson, Steven H Chapman, John A Batsis, Daniel Polsky, Edward V Nunes, Katherine M Seavey, Lisa A Marsch
Workshop on Implementation Science and Digital Therapeutics for Behavioral Health. JMIR mental health 8 (1) (2021)
Marc Fishman, Kevin Wenzel PhD, Jennifer Scodes, Martina Pavlicova, Aimee N C Campbell, John Rotrosen, Edward V Nunes
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial. The American journal on addictions 30 (5) (2021)
Edward V Nunes, Kevin Kunz, Marc Galanter, Patrick G O'Connor
Addiction Psychiatry and Addiction Medicine: The Evolution of Addiction Physician Specialists. The American journal on addictions 29 (5) (2021)
Brandy F Henry, Amar D Mandavia, Margaret M Paschen-Wolff, Timothy Hunt, Jennifer L Humensky, Elwin Wu, Harold A Pincus, Edward V Nunes, Frances R Levin, Nabila El-Bassel
COVID-19, mental health, and opioid use disorder: Old and new public health crises intertwine. Psychological trauma : theory, research, practice and policy 12 (S1) (2020)
Matthew Randesi, John Rotrosen, Edward V Nunes, Joshua D Lee, Patricia Novo, Orna Levran, Jurg Ott, Martina Pavlicova, Jennifer Scodes, Mary Jeanne Kreek
Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians. The American journal of drug and alcohol abuse 46 (6) (2020)
Alan J Budney, Lisa A Marsch, Will M Aklin, Jacob T Borodovsky, Mary F Brunette, Andrew T Campbell, Jesse Dallery, David Kotz, Ashley A Knapp, Sarah E Lord, Edward V Nunes, Emily A Scherer, Catherine Stanger, William C Torrey
Workshop on the Development and Evaluation of Digital Therapeutics for Health Behavior Change: Science, Methods, and Projects. JMIR mental health 7 (2) (2020)
Edward V Nunes, Adam Bisaga, Evgeny Krupitsky, Narinder Nangia, Bernard L Silverman, Sarah C Akerman, Maria A Sullivan
Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. Addiction (Abingdon, England) 115 (11) (2020)
Jeremy D Kidd, Jennifer L Smith, Mei-Chen Hu, Eva M Turrigiano, Adam Bisaga, Edward V Nunes, Frances R Levin
Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Curriculum. Advances in medical education and practice 11 (2020)
Michael Frost, Genie L Bailey, Nicholas Lintzeris, Sir John Strang, Adrian Dunlop, Edward V Nunes, Jakob Billeskov Jansen, Lars Chemnitz Frey, Bernd Weber, Paul Haber, Sonia Oosman, Sonnie Kim, Fredrik Tiberg
Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder. Addiction (Abingdon, England) 114 (8) (2019)
Edward V Nunes, Adam Bisaga, Evgeny M Krupitsky, Narinder Nangia, Bernard L Silverman, Sarah C Akerman, Maria A Sullivan
Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. Addiction (Abingdon, England) 115 (2) (2019)
Edward V Nunes, Matisyahu Shulman
Commentary on Stein et al. (2020): Whither detoxification in the face of the opioid epidemic? Addiction (Abingdon, England) 115 (1) (2019)

Edward V Nunes.css-eqlu8i{font-size:small;padding-left:4px;} (Edward Nunes)

Publication Activity (10 Years)

Top Topics

Top Venues

Edward V Nunes (Edward Nunes)